Salivary gland disease in pediatric HIV patients: An update

Journal of Dentistry for Children

Volumn 71, Issue 1, 2004, Pages 33-37

  Pinto, Andres ^a   De Rossi, Scott S ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Children; HIV Infection; Salivary Gland Disease

Indexed keywords

ANTIRETROVIRUS AGENT; CHOLINERGIC RECEPTOR STIMULATING AGENT; CIVEMELINE; CLINDAMYCIN; DOXYCYCLINE; FLUORIDE; KETOCONAZOLE; NYSTATIN; PENICILLIN G; PILOCARPINE; STEROID; SUCROSE; UNCLASSIFIED DRUG;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; DENTIST; DISEASE COURSE; GASTROINTESTINAL SYMPTOM; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOMEOSTASIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER TOXICITY; MALIGNANT NEOPLASTIC DISEASE; MORBIDITY; MOUTH CAVITY; PAROTID GLAND DISEASE; PAROTITIS; QUANTITATIVE ANALYSIS; RADIATION; REVIEW; SALIVA; SALIVARY GLAND DISEASE; SIDE EFFECT; SYMPTOMATOLOGY; XEROSTOMIA;

ANTI-BACTERIAL AGENTS; ANTIFUNGAL AGENTS; CANDIDIASIS, ORAL; CHILD; CHOLINERGIC AGENTS; HIV INFECTIONS; HUMANS; PAROTITIS; SALIVARY GLAND DISEASES; XEROSTOMIA;

EID: 3142619524     PISSN: 15518949     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (39)

1. Leggott PJ. Oral Manifestations of HIV infection in children. Oral Surg Oral Med Oral Pathol. 1992;73:187-192.
2. Schiodt M. HIV-associated salivary gland disease: A review. Oral Surg Oral Med Oral Pathol. 1992;73:164-167.
3. Flanagan MA, Barasch A, Koenisberg SR. Prevalence of oral soft tissue lesions in HIV-infected minority children treated with highly active antiretroviral therapies. Pediatr Dent. 2000;22:287-291.
4. Ramos-Gomez FJ, Flaitz C, Catapano P, Murray P, Milnes AR, Dorenbaum A. Classification, diagnostic criteria, and treatment recommendations for orofacial manifestations in HIV-infected pediatric patients. Collaborative Workgroup on Oral Manifestations of Pediatric HIV Infection. J Clin Pediatr Dent. 1999;23:85-96.
5. Khongkunthian P, Grote M, Isaratanan W, Piyaworawong S, Reichart PA. Oral manifestations in 45 HIV-positive children from Northern Thailand. J Oral Pathol Med. 2001;(9):549-52.
6. Barasch A, Safford MM, Catalanotto FA, Fine DH, Katz RV. Oral soft tissue manifestations in HIV positive versus HIV-negative children from an inner city population: A two-year observational study. Pediatr Dent. 2000;22(3):215-20.
7. Flaitz C, Wullbrandt B, Sexton J, Bourdon T, Hicks J. Prevalence of orodental findings in HIV-infected Romanian children. Pediatr Dent. 2001;23(1):44-50.
8. Fonseca R, Cardoso AS, Pomarico I. Frequency of oral manifestations in children infected with human immunodeficiency virus. Quintessence Int. 2000;31:419-422.
9. Geeenspan D, Greenspan JS. HIV-related oral disease. Lancet. 1996;348:729-733.
10. Arendorf TM, Bredekamp B, Cloete CA, Sauer G. Oral manifestation of HIV infection in 600 South African patients. J Oral Pathol Med. 1998;27:176-9.
11. Schiodt M, Greenspan D, Levy JA, et al. Does HIV cause salivary gland disease? AIDS. 1989;3:819-22.
12. Schuval SJ, Bonagura VR, Ilowite NT. Rheumatologic manifestations of pediatric immunodeficiency virus infection. J Rheumatol. 1993;20:1578-1582.
13. Mandel L, Surattanot F. Bilateral parotid swelling: A review. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2002;93:221-237.
14. Soberman N, Leonidas JC, Berdon WE, Bonagura V, et al. Parotid enlargement in children seropositive for human immunodeficiency virus: Imaging findings. AJR Am J Roentgenol. 1991;157:553-556.
15. Marolda J, Pace B, Bonforte RJ, Kotin NM, Rabinowitz J, Kattan M. Pulmonary manifestations of HIV infection in children. Pediatr Pulmonol. 1991;10:231-5.
16. Itescu S, Brancato LJ, Buxbaum J, et al. A diffuse infiltrative CD8 lymphocytosis syndrome in human immunodeficiency virus (HIV) infection: A host immune response associated with HLA-DR5. Ann Intern Med. 1990;112:3-10.
17. Mandel L. Ultrasound findings in HIV-positive patients with parotid gland swellings. J Oral Maxillofac Surg. 2001;59:283-286.
18. Mayer M, Haddad J Jr. Human immunodefiency virus infection presenting with lymphoepithelial cysts in a 6-year-old child. Ann Otol Rhinol Laryngol. 1996;105:242-244.
19. Schuval SJ, O'Reilly ME, Bonagura VR. Increased frequency of HLA-DR11 in pediatric human immunodeficiency virus-associated parotid gland enlargement. Clin Diagn Lab Immunol. 1997;4:258-260.
20. Asher RS, McDowell J, Acs G, Belanger G. Pediatric infection with the human immunodeficiency virus (HIV): Head, neck, and oral manifestations. Spec Care Dentist. 1993;13:113-6.
21. Fox P. Salivary gland involvement in HIV-1 infection. Oral Surg Oral Med Oral Pathol. 1992;73:168-170.
22. Chetty R, Vaithilingum M, Theipal R. Epstein-barr virus and the histopathological changes of parotid gland lymphoid infiltrates in HIV-positive children. Pathology. 1999;31:413-417.
23. Shiboski CH, Wilson CM, Greenspan D, Hilton J, Greenspan JS, Moscicki AB. Adolescent Medicine HIV/AIDS Research Network HIV-related oral manifestations among adolescents in a multicenter cohort study. J Adolesc Health. 2001;29(3 Suppl): 109-14.
24. Chetty R. Parotid MALT lymphoma in an HIV positive child. Histopathology. 1996;29:195-197.
25. Corr P, Vaithilingum M, Thejpal R, Jeena P. Parotid MALT lymphoma in HIV infected children. J Ultrasound Med. 1997;16:615-7.
26. Santos LC, Castro GF, de Souza IP, Oliveira RH. Oral manifestations related to immunosuppression degree in HIV-positive children. Braz Dent J. 2001;12:135-8.
27. Hanekom WA, Chadwick EG, Yogev R. Pneumococcal parotitis in a human immunodeficiency virus-infected child. Pediatr Infect Dis J. 1995;14:1113-1114.
28. Katz BZ. Recurrent parotitis in childhood. Clin Pediatr 1993;32:127.
29. Younai FS, Marcus M, Freed JR, et al. Self-reported oral dryness and HIV disease in a national sample of patients receiving medical care. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001;92:629-36.
30. Howell RB, Jandinski JJ, Palumbo P, Shey Z, Houpt MI. Oral soft tissue manifestations and CD4 lymphocyte counts in HIV-infected children. Pediatr Dent. 1996;18:117-20.
31. Hodgson TA. HIV-associated oral lesions: Prevalence in Zambia. Oral Dis. 1997;3(suppl 2):S46-50.
32. Ramos-Gomez F. Dental considerations for the paediatric AIDS/HIV patient. Oral Dis. 2002;8(suppl. 2):49-54.
33. Kozinetz CA, Carter AB, Simon C, Hicks MJ, Rossmann SN, Flaitz CM. Oral manifestations of pediatric vertical HIV infection. AIDS Patient Care STDS. 2000;14:89-94.
34. Bretz WA, do Valle EV, Jacobson JJ, Marchi F, Mendes S, Nor JE, et al. Unstimulated salivary flow rates of young children. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001;91:541-5.
35. Costa LR, Villena RS, Sucasas PS, Birman EG. Oral findings in pediatric AIDS: A case control study in Brazilian children. J Dent Child. 1998;65:186-90.
36. Madigan A, Murray PA, Houpt M, Catalanotto F, Feuerman M. Caries experience and cariogenic markers in HIV-positive children and their siblings. Pediatr Dent. 1996;18:129-36.
37. Fox PC, Wolff A, Yeh CK, Atkinson JC, Baum BJ. Salivary inhibition of HPV-1 infectivity: Functional properties and distribution in men, women, and children. J Am Dent Assoc. 1989;118:709-11.
38. Patton LL, McKaig R, Strauss R, Rogers D, Eron JJ Jr. Changing prevalence of oral manifestations of human immuno-deficiency virus in the era of protease inhibitor therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2000;89:299-304.
39. Suskind DL, Tavill MA, Handler SD. Doxycycline sclerotherapy of benign lymphoepithelial cysts of the parotid: A minimally invasive treatment. Int J Pediatr Otorhinolaryngol. 2000;52:157-161.